Wall Street Zen upgraded shares of Aligos Therapeutics (NASDAQ:ALGS – Free Report) from a strong sell rating to a hold rating in a research report report published on Sunday. A number of other brokerages have also weighed in on ALGS. Westpark Capital assumed coverage on shares of Aligos Therapeutics in a report on Thursday, March […]

Wall Street Zen upgraded shares of Texas Capital Bancshares (NASDAQ:TCBI – Free Report) from a sell rating to a hold rating in a research note issued to investors on Sunday morning. A number of other analysts have also weighed in on TCBI. Hovde Group upped their price objective on shares of Texas Capital Bancshares from […]

Wall Street Zen upgraded shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) from a sell rating to a hold rating in a research report report published on Sunday. A number of other equities analysts have also weighed in on the stock. HC Wainwright upped their price target on shares of Nektar Therapeutics from $165.00 to […]

Wall Street Zen upgraded shares of FRP (NASDAQ:FRPH – Free Report) from a sell rating to a hold rating in a research note published on Saturday morning. Separately, Weiss Ratings reissued a “sell (d+)” rating on shares of FRP in a research note on Friday, March 27th. One analyst has rated the stock with a […]

Wall Street Zen upgraded shares of Mammoth Energy Services (NASDAQ:TUSK – Free Report) from a sell rating to a hold rating in a research note published on Saturday. Mammoth Energy Services Trading Down 2.1% Shares of TUSK stock opened at $3.20 on Friday. Mammoth Energy Services has a 12 month low of $1.72 and a […]

Wall Street Zen upgraded shares of Climb Bio (NASDAQ:CLYM – Free Report) from a sell rating to a hold rating in a research report report published on Saturday morning. Other analysts also recently issued reports about the stock. Oppenheimer boosted their target price on shares of Climb Bio from $10.00 to $18.00 and gave the […]

Wall Street Zen upgraded shares of Lindblad Expeditions (NASDAQ:LIND – Free Report) from a hold rating to a buy rating in a research note published on Saturday. LIND has been the subject of a number of other research reports. Stifel Nicolaus upped their target price on shares of Lindblad Expeditions from $20.00 to $23.00 and […]